for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Health

Sanofi continues to enroll patients for other diseases treatment: CEO

FILE PHOTO: A logo of Sanofi is pictured during the company's shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit Tessier

PARIS (Reuters) - French drugmaker Sanofi SASY.PA continues to enroll patients for the treatment of diseases other than COVID-19 and maintains a 100% capacity to manufacture drugs, its chief executive said on Monday.

CEO Paul Hudson was speaking at a Financial Times event.

Reporting by Matthias Blamont; Writing by Dominique Vidalon; Editing by Edmund Blair

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up